Cause of Corona Virus
The primary mode of transmission is via respiratory droplets that people exhale, for example when coughing or sneezing. These only stay suspended in the air for a short time but may stay viable and contagious on a metal, glass or plastic surface. Details for the COVID-19 virus are not available as of 26 February 2020, and it is assumed that they are similar to other coronaviruses, which survive for up to nine days at room temperature. Disinfection of surfaces is possible with substances such as 62–71% ethanol applied for one minute. There were speculations that the virus can spread from goods imported from China, but there are no evidences of proof on the same. As the virus do no live long on surfaces and are very unlikely to survive over a period of days and weeks when an item is being shipped from China.
Treatment and Cure of Corona Virus
There is currently no vaccine to prevent the coronavirus.
The National Institute of Allergy and Infectious Diseases may begin clinical trials on a vaccine within weeks, though the vaccine would not be available for at least another year.
There is currently no treatment for the coronavirus. Patients are helped by what’s called supportive care, for example, to help them breathe.
A group of coronavirus patients in Nebraska are taking part in a clinical trial for a possible treatment with an antiviral drug called remdesivir. Originally developed for possible treatment for Ebola, the drug has previously shown promise in treating other coronaviruses, such as SARS.
Other clinical trials of remdesivir are ongoing in China to test its effects on both severe and mild cases of the disease, according to Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Disease. In China, the Chinese Center for Disease Control and Prevention (CCDC), and Shanghai East Hospital are developing vaccines. In Hong Kong, the University of Hong Kong is developing vaccines. The Norwegian Coalition for Epidemic Preparedness Innovations (CEPI) is funding three vaccine projects and hopes to have a vaccine in trials by June 2020, and approved and ready in a year. The U.S. National Institutes of Health (NIH) is hoping for human trials of a vaccine by April 2020.